Summary:
Were you or a loved one diagnosed with mild to moderate Alzheimer’s disease? You or they may be eligible for an Alzheimer’s study.
A clinical trial evaluating a potential new medication for confusion associated with Alzheimer’s disease has started enrolling participants in your local area.
You or someone you know may be able to join if they:
- are between 55–80 years of age
- have been diagnosed with Alzheimer’s
Participants must have a “study partner” who knows them well and can attend all the study visits.
Participants will help determine if the potential new medication is safe and whether it works in people with Alzheimer’s.